Mericli Alexander F, Asaad Malke, Lewis Valerae O, Lin Patrick P, Goodenough Christopher J, Adelman David M, Oates Scott D, Hanasono Matthew M
From the Departments of Plastic Surgery.
Orthopaedic Oncology, University of Texas M. D. Anderson Cancer Center.
Plast Reconstr Surg. 2023 Apr 1;151(4):885-896. doi: 10.1097/PRS.0000000000010014. Epub 2022 Dec 9.
The goal of this study was to evaluate outcomes after vascularized bone flap (VBF) reconstruction of oncologic bony extremity defects. A secondary goal was to compare union rates based on various insetting methods, including onlay, intermedullary, and intercalary.
The authors conducted a retrospective review of consecutive patients who received an extremity reconstruction with a fibula flap after oncologic resection between 2001 and 2019.
The authors identified a total of 60 fibular VBFs in 55 patients (67% lower extremity, 33% upper extremity). The overall union rate was 91.7% (55 of 60). For lower extremity reconstructions, the mean time to full weightbearing was 16 months (range, 4 to 44 months). Fibula VBFs were onlay in 65% of cases, intercalary in 23%, and intramedullary in 12%. Forty-three percent of patients required a reoperation as a result of a surgical complication. Immediate femur reconstruction subgroup analysis demonstrated that onlay fibula flap orientation was associated with a significantly increased risk for any complication (odds ratio, 6.3; 95% CI, 1.4 to 28.7; P = 0.03) as well as an increased risk for requiring conversion to endoprostheses because of nonunion (OR, 12.1; 90% CI, 1.03 to 143.5; P = 0.03) compared with intramedullary placement.
The free vascularized fibula flap is a reliable option for functional reconstruction of any long bone extremity defect, but complications in these complex procedures are not uncommon. In patients with immediate femur reconstructions, intramedullary fibula placement was associated with significantly lower complication and lower metallic implant conversion rates and a trend toward a more rapid early union compared with onlay VBF.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
本研究的目的是评估血管化骨瓣(VBF)重建肿瘤性肢体骨缺损后的结果。次要目的是比较基于各种植入方法(包括贴附、髓内和节段间)的骨愈合率。
作者对2001年至2019年间因肿瘤切除后接受腓骨瓣肢体重建的连续患者进行了回顾性研究。
作者共确定了55例患者中的60个腓骨VBF(67%为下肢,33%为上肢)。总体骨愈合率为91.7%(60例中的55例)。对于下肢重建,完全负重的平均时间为16个月(范围为4至44个月)。65%的病例采用贴附式腓骨VBF,23%为节段间式,12%为髓内式。43%的患者因手术并发症需要再次手术。即刻股骨重建亚组分析表明,与髓内植入相比,贴附式腓骨瓣方向与任何并发症的风险显著增加相关(优势比,6.3;95%可信区间,1.4至28.7;P = 0.03),以及因骨不连而需要转换为假体的风险增加(优势比,12.1;90%可信区间,1.03至143.5;P = 0.03)。
游离血管化腓骨瓣是功能性重建任何长骨肢体缺损的可靠选择,但这些复杂手术中的并发症并不少见。在即刻股骨重建的患者中,与贴附式VBF相比,髓内腓骨植入与显著更低的并发症和更低的金属植入物转换率相关,并且有早期愈合更快的趋势。
临床问题/证据水平:治疗性,III级。